WPI 3355 (Nateglinide 120 mg)
Pill imprint WPI 3355 has been identified as Nateglinide 120 mg.
Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 3355 (Nateglinide 120 mg)
Nateglinide
- Imprint:
-
WPI
3355 - Strength:
- 120 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Meglitinides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Laboratories Inc.
- National Drug Code (NDC):
- 00591-3355
More resources
Nateglinide is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
